148 related articles for article (PubMed ID: 24769518)
1. Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma.
Eisa NH; Ebrahim MA; Ragab M; Eissa LA; El-Gayar AM
J Oncol Pharm Pract; 2015 Oct; 21(5):323-30. PubMed ID: 24769518
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.
Ulu M; Alacacioglu A; Yuksel E; Pamukk BO; Bozkaya G; Ari A; Yuksel A; Sop G; Alacacioglu I
Saudi J Gastroenterol; 2015; 21(1):47-50. PubMed ID: 25672239
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the clinical significance of serum vascular endothelial growth factor and matrix metalloproteinase-9 in patients with hepatocellular carcinoma.
Kamel L; Nessim I; Abd-el-Hady A; Ghali A; Ismail A
J Egypt Soc Parasitol; 2005 Dec; 35(3):875-90. PubMed ID: 16333896
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum matrix metalloproteinase (MMP)-9 to MMP-2 ratio as a biomarker in hepatocellular carcinoma.
Yeh HC; Lin SM; Chen MF; Pan TL; Wang PW; Yeh CT
Hepatogastroenterology; 2010; 57(97):98-102. PubMed ID: 20422881
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
[TBL] [Abstract][Full Text] [Related]
6. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
Nart D; Yaman B; Yilmaz F; Zeytunlu M; Karasu Z; Kiliç M
Liver Transpl; 2010 May; 16(5):621-30. PubMed ID: 20440771
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Prognostic Value of Talin-1 and Midkine as Tumor Markers in Hepatocellular Carcinoma in Egyptian Patients.
Mashaly AH; Anwar R; Ebrahim MA; Eissa LA; El Shishtawy MM
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1503-1508. PubMed ID: 29936723
[TBL] [Abstract][Full Text] [Related]
10. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
[TBL] [Abstract][Full Text] [Related]
11. Plasma matrix metalloproteinase-9 (gelatinase B) in patients with hepatocellular carcinoma.
Murawaki Y; Ikuta Y; Okamoto K; Mimura K; Koda M; Kawasaki H
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):351-7. PubMed ID: 11958288
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma.
Kuyvenhoven JP; van Hoek B; Blom E; van Duijn W; Hanemaaijer R; Verheijen JH; Lamers CB; Verspaget HW
Thromb Haemost; 2003 Apr; 89(4):718-25. PubMed ID: 12669127
[TBL] [Abstract][Full Text] [Related]
13. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
14. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
16. Pigment epithelium-derived factor and matrix metalloproteinase-9 in liver cirrhosis.
Kozlowska J; Mikula T; Suchacz M; Jabnonska J; Stanczak W; Cianciara J; Wiercinska-Drapalo A
Saudi J Gastroenterol; 2016; 22(5):375-379. PubMed ID: 27748324
[TBL] [Abstract][Full Text] [Related]
17. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
[TBL] [Abstract][Full Text] [Related]
18. [Serum and tissue expressions of galectin-3 in hepatocellular carcinoma and the clinical significances].
Fang QQ; Ni RZ; Xiao MB; Jiang F; Lu CH
Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):527-31. PubMed ID: 22152245
[TBL] [Abstract][Full Text] [Related]
19. [Expression and prognostic value of galectin-9 in hepatocellular carcinoma patients].
Gu CJ; Wu H; Sheng CY; Ni QC
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(26):2025-8. PubMed ID: 24169278
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
